119-sres232

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 232 Agreed to Senate

    (ATS) ]

<DOC>

119th CONGRESS
 1st Session
S. RES. 232

 Designating May 2025 as ``National Brain Tumor Awareness Month''.

_______________________________________________________________________

 IN THE SENATE OF THE UNITED STATES

 May 15, 2025

 Mr. Daines (for himself and Mr. Markey) submitted the following 
 resolution; which was considered and agreed to

_______________________________________________________________________

 RESOLUTION

 Designating May 2025 as ``National Brain Tumor Awareness Month''.

Whereas it is estimated that more than 93,000 individuals in the United States 
 will be diagnosed with a primary brain tumor each year;
Whereas it is estimated that more than 1,000,000 individuals are living with a 
 brain tumor in the United States;
Whereas, in the United States, brain tumors are--

    (1) the leading cause of death from cancer in children who are under 14 
years of age and teens who are under 19 years of age; and

    (2) the second-leading cause of death from cancer in young adults who 
are between 15 and 39 years of age;

Whereas the average 5-year survival rate for an individual in the United States 
 following the diagnosis of a primary malignant brain tumor is only 35.7 
 percent;
Whereas it is estimated that 18,330 individuals in the United States will die as 
 a result of a malignant brain tumor in 2025;
Whereas brain tumors may be malignant or benign but can be life-threatening in 
 either case;
Whereas treatment of brain tumors is complicated by the fact that more than 100 
 types of brain tumors exist;
Whereas the treatment and removal of brain tumors present significant challenges 
 due to the uniquely complex and fragile nature of the brain;
Whereas brain tumors affect the primary organ in the human body that controls 
 not only cognitive ability, but the actions of every other organ and 
 limb in the body, leading to brain tumors being described as a disease 
 that affects the whole individual;
Whereas brain tumor research is supported by several private, nonprofit research 
 foundations and by Federal medical research institutions;
Whereas basic research may fuel advancements and the development of new 
 treatments for brain tumors;
Whereas obstacles to the development of new treatments for brain tumors remain, 
 and there are limited strategies for the screening or early detection of 
 brain tumors;
Whereas, despite the high number of individuals diagnosed with a brain tumor 
 every year and the devastating prognosis for those individuals, only a 
 few treatments have been approved for malignant brain tumors since the 
 1980s;
Whereas none of the treatments for malignant brain tumors extend survival by 
 more than 2 years on average or are considered to be curative;
Whereas the mortality rates associated with brain tumors have changed little 
 during the 30 years preceding the date of introduction of this 
 resolution;
Whereas there is a need for greater public awareness of brain tumors, including 
 the difficulties associated with research on brain tumors and the 
 opportunities for advances in brain tumor research and treatment; and
Whereas May 2025, during which brain tumor advocates nationwide unite in 
 awareness, outreach, and advocacy activities, is an appropriate month to 
 recognize as ``National Brain Tumor Awareness Month'': Now, therefore, 
 be it
 Resolved, That the Senate--

    (1) designates May 2025 as ``National Brain Tumor Awareness 
 Month'';

    (2) encourages increased public awareness of brain tumors 
 to honor the individuals who have lost their lives to a brain 
 tumor or currently live with a brain tumor diagnosis;

    (3) supports efforts to develop better treatments for brain 
 tumors that will improve the quality of life and the long-term 
 prognosis of individuals diagnosed with a brain tumor;

    (4) expresses its support for individuals who are battling 
 brain tumors, as well as the families, friends, and caregivers 
 of those individuals; and

    (5) urges a collaborative approach to brain tumor research, 
 which is a promising means of advancing understanding of, and 
 treatment for, brain tumors.
 <all>